Sphingolipid metabolism in brain insulin resistance and neurological diseases

Sphingolipids, as members of the large lipid family, are important components of plasma membrane. Sphingolipids participate in biological signal transduction to regulate various important physiological processes such as cell growth, apoptosis, senescence, and differentiation. Numerous studies have d...

Full description

Bibliographic Details
Main Authors: Meng Mei, Maochang Liu, Yan Mei, Jing Zhao, Yang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1243132/full
_version_ 1797665270019391488
author Meng Mei
Maochang Liu
Yan Mei
Jing Zhao
Yang Li
author_facet Meng Mei
Maochang Liu
Yan Mei
Jing Zhao
Yang Li
author_sort Meng Mei
collection DOAJ
description Sphingolipids, as members of the large lipid family, are important components of plasma membrane. Sphingolipids participate in biological signal transduction to regulate various important physiological processes such as cell growth, apoptosis, senescence, and differentiation. Numerous studies have demonstrated that sphingolipids are strongly associated with glucose metabolism and insulin resistance. Insulin resistance, including peripheral insulin resistance and brain insulin resistance, is closely related to the occurrence and development of many metabolic diseases. In addition to metabolic diseases, like type 2 diabetes, brain insulin resistance is also involved in the progression of neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease. However, the specific mechanism of sphingolipids in brain insulin resistance has not been systematically summarized. This article reviews the involvement of sphingolipids in brain insulin resistance, highlighting the role and molecular biological mechanism of sphingolipid metabolism in cognitive dysfunctions and neuropathological abnormalities of the brain.
first_indexed 2024-03-11T19:41:32Z
format Article
id doaj.art-7898b6c082084566b8cdedfee6d8836e
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-11T19:41:32Z
publishDate 2023-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-7898b6c082084566b8cdedfee6d8836e2023-10-06T09:55:29ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-10-011410.3389/fendo.2023.12431321243132Sphingolipid metabolism in brain insulin resistance and neurological diseasesMeng Mei0Maochang Liu1Yan Mei2Jing Zhao3Yang Li4Department of Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaAdministrative Office, Beijing University of Chinese Medicine, Beijing, ChinaDepartment of Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSphingolipids, as members of the large lipid family, are important components of plasma membrane. Sphingolipids participate in biological signal transduction to regulate various important physiological processes such as cell growth, apoptosis, senescence, and differentiation. Numerous studies have demonstrated that sphingolipids are strongly associated with glucose metabolism and insulin resistance. Insulin resistance, including peripheral insulin resistance and brain insulin resistance, is closely related to the occurrence and development of many metabolic diseases. In addition to metabolic diseases, like type 2 diabetes, brain insulin resistance is also involved in the progression of neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease. However, the specific mechanism of sphingolipids in brain insulin resistance has not been systematically summarized. This article reviews the involvement of sphingolipids in brain insulin resistance, highlighting the role and molecular biological mechanism of sphingolipid metabolism in cognitive dysfunctions and neuropathological abnormalities of the brain.https://www.frontiersin.org/articles/10.3389/fendo.2023.1243132/fullsphingolipid metabolismbrain insulin resistanceceramidesphingosine-1-phosphateAlzheimer’s diseaseParkinson’s disease
spellingShingle Meng Mei
Maochang Liu
Yan Mei
Jing Zhao
Yang Li
Sphingolipid metabolism in brain insulin resistance and neurological diseases
Frontiers in Endocrinology
sphingolipid metabolism
brain insulin resistance
ceramide
sphingosine-1-phosphate
Alzheimer’s disease
Parkinson’s disease
title Sphingolipid metabolism in brain insulin resistance and neurological diseases
title_full Sphingolipid metabolism in brain insulin resistance and neurological diseases
title_fullStr Sphingolipid metabolism in brain insulin resistance and neurological diseases
title_full_unstemmed Sphingolipid metabolism in brain insulin resistance and neurological diseases
title_short Sphingolipid metabolism in brain insulin resistance and neurological diseases
title_sort sphingolipid metabolism in brain insulin resistance and neurological diseases
topic sphingolipid metabolism
brain insulin resistance
ceramide
sphingosine-1-phosphate
Alzheimer’s disease
Parkinson’s disease
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1243132/full
work_keys_str_mv AT mengmei sphingolipidmetabolisminbraininsulinresistanceandneurologicaldiseases
AT maochangliu sphingolipidmetabolisminbraininsulinresistanceandneurologicaldiseases
AT yanmei sphingolipidmetabolisminbraininsulinresistanceandneurologicaldiseases
AT jingzhao sphingolipidmetabolisminbraininsulinresistanceandneurologicaldiseases
AT yangli sphingolipidmetabolisminbraininsulinresistanceandneurologicaldiseases